| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 04/24/2003 | WO2003033534A2 Ngzipa, ngzipd, pgzipa, and pgzipd polynucleotides and polypeptides and uses thereof |
| 04/24/2003 | WO2003033533A1 Microfluidized leishmania antigen and methods of making and using thereof |
| 04/24/2003 | WO2003033519A2 Intact minicells as vectors for dna transfer and gene therapy in vitro and in vivo |
| 04/24/2003 | WO2003033418A1 Organic waste treatment |
| 04/24/2003 | WO2003032913A2 Methods and compositions for targeting proteins across the blood brain barrier |
| 04/24/2003 | WO2003032898A2 Modified human thymic stromal lymphopoietin |
| 04/24/2003 | WO2003032727A1 Methods and compositions for targeting underglycosylated proteins across the blood brain barrier |
| 04/24/2003 | WO2003005964A3 Recombinant vsv for the treatment of tumor cells |
| 04/24/2003 | WO2003000910A3 Metabolic controlled fermentation process for pseudomonic acid production |
| 04/24/2003 | WO2002098907A3 Cation conducting gabaa receptors and their use |
| 04/24/2003 | WO2002091824A3 Biological-chemical fungicide compositions and methods of use |
| 04/24/2003 | WO2002085295A3 Methods and compositions for the modulation of biofilm formation |
| 04/24/2003 | WO2002079406A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr protein, and uses thereof |
| 04/24/2003 | WO2002072822A3 Als2 gene and amyotrophic lateral sclerosis type 2 |
| 04/24/2003 | WO2002066507A3 Histidine phosphatase interacting protein of 120 kd |
| 04/24/2003 | WO2002061039A3 Thuja plicata dirigent protein promotors |
| 04/24/2003 | WO2002060938A3 Haemophilus influenza basb212 polynucleotides, polypeptides and use thereof |
| 04/24/2003 | WO2002057432A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 04/24/2003 | WO2002056900A3 Use of slpi for treating chronic inflammatory intestinal diseases |
| 04/24/2003 | WO2002055717A3 Enhanced secretion of a polypeptide by a microorganism |
| 04/24/2003 | WO2002050120A3 High affinity antibodies |
| 04/24/2003 | WO2002046383A3 Protein modification and maintenance molecules |
| 04/24/2003 | WO2002040746A9 Preventing corrosion with beneficial biofilms |
| 04/24/2003 | WO2002040688A3 Maize yellow stripe1 and related genes |
| 04/24/2003 | WO2002026825A3 G-protein coupled receptors |
| 04/24/2003 | WO2002018585A8 Packaging of positive-strand rna virus replicon particles |
| 04/24/2003 | WO2002006490A8 Lipoxygenase genes, promoters, transit peptides and proteins thereof |
| 04/24/2003 | WO2002004513A3 Down syndrome critical region 1-like 1 proteins |
| 04/24/2003 | WO2002000878A3 Human msp1 mitochondrial dynamin, its msp1-x isoforms, and their therapeutic use |
| 04/24/2003 | WO2001078796A3 Type ii gonadotropin-releasing hormone receptor and polynucleotides encoding therefor |
| 04/24/2003 | WO2001077389A3 Genes expressed in foam cell differentiation |
| 04/24/2003 | WO2001075440A3 Schizophrenia related genes |
| 04/24/2003 | US20030079255 Methods for the production of tyrosine, cinnamic acid and para-hydroxycinnamic acid |
| 04/24/2003 | US20030079253 Immunoglobulin binding protein arrays in eukaryotic cells |
| 04/24/2003 | US20030079238 Polynucleotide encoding a human junctional adhesion protein (JAM-2) |
| 04/24/2003 | US20030079237 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders |
| 04/24/2003 | US20030078672 Polysaccharide sponges for cell culture and transplantation |
| 04/24/2003 | US20030078410 Expression vector for use in the transfer of genes and preparation of vaccines |
| 04/24/2003 | US20030078405 47 human secreted proteins |
| 04/24/2003 | US20030078395 Nucleotide sequences coding polypeptide for use in the treatment of hyperlipemia |
| 04/24/2003 | US20030078390 Tissue cement proteins from Rhipicephalus appendiculatus |
| 04/24/2003 | US20030078386 Antibody for use in the treatment of viral, gastrointestinal, autoimmune and cell proiferative disorders |
| 04/24/2003 | US20030078383 Novel human LDL receptor family proteins and polynucleotides encoding the same |
| 04/24/2003 | US20030078382 Human Ect2 and methods of use |
| 04/24/2003 | US20030078373 Chaperone fragments |
| 04/24/2003 | US20030078370 Antibodies to cyclin E2 protein |
| 04/24/2003 | US20030078204 Produced in prokaryotic cells |
| 04/24/2003 | US20030078177 Proteases from gram positive organisms |
| 04/24/2003 | US20030077831 Nucleotide sequences for use as efficient gene transfer and cloning tool in genetic engineering |
| 04/24/2003 | US20030077830 Ketogulonigenium endogenous plasmids |
| 04/24/2003 | US20030077827 Transfection of preferential cells; obtain immbolized nucleotide sequences, incubate with cells, recover transfected cells |
| 04/24/2003 | US20030077826 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (PTPC) |
| 04/24/2003 | US20030077820 Novel human collagen proteins and polynucleotides encoding the same |
| 04/24/2003 | US20030077809 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of cancer, inflammation and skin disorders |
| 04/24/2003 | US20030077807 Subtilisin variants |
| 04/24/2003 | US20030077804 Composition containing protein for use as cloning tool in genetic engineering |
| 04/24/2003 | US20030077802 Human PRL1 phosphatase |
| 04/24/2003 | US20030077797 Xylitol dehydrogenase of acetic acid bacteria and gene thereof |
| 04/24/2003 | US20030077767 Nucleotide sequences coding polypeptide for use in biosynthesis of anthramycin |
| 04/24/2003 | US20030077766 L-cysteine producing bacterium and method for producing L-cysteine |
| 04/24/2003 | US20030077763 Polymer grafting by polysaccharide synthases |
| 04/24/2003 | US20030077760 Combinatorial polyketide libraries produced using a modular PKS gene cluster as scaffold |
| 04/24/2003 | US20030077759 Plasmid coding polyketides for use in human therapeutices, veterinary medicine and agriculture |
| 04/24/2003 | US20030077750 Peptide for use in human therapeutics and diagnostics |
| 04/24/2003 | US20030077749 Ucp5 |
| 04/24/2003 | US20030077747 Polypeptide for use in the diagnosis, treatment, and prevention of cardiovascular, aging, fatty acid metabolism and cancer disorders |
| 04/24/2003 | US20030077739 Generation of preferential antibody; obtain nucleotide sequences coding antibody, insert into vector, transform vector into cell, express vector, recover antibody |
| 04/24/2003 | US20030077735 Novel human Kchannel and therapeutic applications thereof |
| 04/24/2003 | US20030077734 Isolated human G-protein coupled receptors, nucleic acid molecules encoding human GPCR proteins, and uses thereof |
| 04/24/2003 | US20030077729 Novel secretion factors for gram-positive micoorganisms, genes encoding them and methods of using it |
| 04/24/2003 | US20030077709 Novel leukotriene B4 receptor |
| 04/24/2003 | US20030077707 Adjusting transferase domain in modular polyketide synthase; obtain nucleotide sequences, adjust sequences, express sequences, monitor activity of synthase |
| 04/24/2003 | US20030077706 Mouse cytokine receptor |
| 04/24/2003 | US20030077705 Nucleotide sequences coding polypeptide for use in the treatment of inflammation and ischemia-reperfusion injury |
| 04/24/2003 | US20030077702 Preparing gnetically engineered glucose oxidase; obtain nucleotide sequence coding glucose oxidase, mutate sequence, insert into vector, transform cells, propagate cells, express vector, monitor glucose oxidase expression |
| 04/24/2003 | US20030077698 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/24/2003 | US20030077694 Nucleotide sequences coding polypeptide for use in the treatment of inflammatory disorders |
| 04/24/2003 | US20030077691 Nucleotide sequences coding polypeptide for use in production of carotenoids |
| 04/24/2003 | US20030077683 IKK-alpha proteins, nucleic acids and methods |
| 04/24/2003 | US20030077677 High throughput screening for sequences of interest |
| 04/24/2003 | US20030077671 Detection of modulator of transport protein activity; obtain sample containing transport protein, incubate with potential modulator, monitor binding activity, reduction in binding indicates effective modulator |
| 04/24/2003 | US20030077657 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/24/2003 | US20030077620 High throughput screening for sequences of interest |
| 04/24/2003 | US20030077601 Nucleic acid fragments for the identification of dechlorinating bacteria |
| 04/24/2003 | US20030077585 Nucleotide sequences coding polypeptide for use in the diagnosis, detection, prevention and treatment of bacterial infection |
| 04/24/2003 | US20030077293 Streptococcus antigens |
| 04/24/2003 | US20030077280 Monoclonal antibody which specifically recognizes and forms complex with protein located on surface of activated T cells and thereby inhibits T cell activation of B cells |
| 04/24/2003 | US20030077277 Human antibodies that have MN binding and cell adhesion-neutralizing activity |
| 04/24/2003 | US20030077269 To increase levels of skin and mucosal ceramides; dermatological and cosmetic compositions containing same which are suitable for topical application |
| 04/24/2003 | US20030077255 Compositions of bacteria and alpha-lactalbumin and uses thereof |
| 04/24/2003 | US20030077246 TNFr/OPG-like molecules and uses thereof |
| 04/24/2003 | US20030075446 Microfluidic systems and methods of transport and lysis of cells and analysis of cell lysate |
| 04/24/2003 | CA2775218A1 Intact minicells as vectors for dna transfer and gene therapy in vitro and in vivo |
| 04/24/2003 | CA2494706A1 Chimeric glycosylphosphatidylinositol containing peptides |
| 04/24/2003 | CA2463943A1 Human antibodies that have mn binding and cell adhesion-neutralizing activity |
| 04/24/2003 | CA2463925A1 Bone anti-resorptive compounds |
| 04/24/2003 | CA2463916A1 Gene of enzyme reactivating dna damaged by ultraviolet light using visible light |
| 04/24/2003 | CA2463672A1 Direct targeting binding proteins |
| 04/24/2003 | CA2463634A1 Anti-hla-dr antibody |
| 04/24/2003 | CA2463593A1 Fluorescent protein |